AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tubitere 120mg Injection

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Docetaxel (120mg)

Overview Tubitere 120mg Injection

Oncaspar 120mg Injection is a chemotherapy agent indicated for treating breast, non-small cell lung, prostate, and head and neck cancers. Administration is strictly via injection by a healthcare professional. Dosage and frequency are determined individually by your physician, depending on your specific cancer and may vary. Adhere precisely to your doctor's prescribed regimen. Improper use or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under your doctor's guidance. Common side effects include shortness of breath, constipation, swelling, infections, appetite loss, myalgia, nail abnormalities, pain, and fatigue. Your physician may prescribe additional medications to mitigate these. Report immediately any unusual bleeding or bruising, sore throat, mouth sores, or high fever. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests to monitor blood cell levels and liver function are essential throughout treatment. Prior to commencing treatment, disclose any existing heart, liver, or kidney conditions, and all medications, including antibiotics, to your doctor. Interactions with other drugs are possible; inform your physician of all concurrent medications. This injection is contraindicated during pregnancy and breastfeeding. Reliable contraception is crucial for both partners during treatment to prevent conception.

Uses of Tubitere 120mg Injection

Cancers of the breast, lung (non-small cell), prostate, and head and neck.

Major Benefits of Tubitere 120mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Tubitere 120mg Injection:

  • Breathlessness
  • Constipation
  • Edema (swelling)
  • Infection
  • Loss of appetite
  • Muscle pain
  • Nail disorder
  • Pain
  • Weakness

How to use Tubitere 120mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Tubitere 120mg Injection works:

Oncaspar 120mg Injection is a cancer treatment that disrupts microtubule networks, essential for cancer cell division and proliferation. This action inhibits cancer cell growth, ultimately leading to their demise.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while using Tubitere 120mg Injection.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Tubitere 120mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

Administration of Tubitere 120mg Injection is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Tubitere 120mg Injection on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Tubitere 120mg Injection poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.

LiverLiverCAUTION

Individuals with hepatic impairment should use Tubitere 120mg Injection cautiously. Dosage modification of Tubitere 120mg Injection might be necessary. Physician consultation is advised.

What if you forget to take Tubitere 120mg Injection :

NA

Facts to Know About Tubitere 120mg Injection

LabelValue
Type of Compound Taxane-based medications
Addictive None.
Type of Medication Cancer-fighting drugs
Mechanism of Action Microtubule-targeting drugs: Taxane class

FAQs on Tubitere 120mg Injection

Weight gain is a potential side effect of Tubitere 120mg Injection. This can result from fluid retention, often manifesting initially as swollen feet, which may subsequently affect the entire body. Contact your physician promptly if you experience foot swelling.
Maintain Tubitere 120mg Injection administration under your physician's guidance. Treatment length depends on your specific cancer and individual response to therapy. Infusion frequency is typically every three weeks.
Tubitere 120mg Injection includes alcohol, potentially causing dizziness, drowsiness, unsteady gait, and intoxication-like symptoms. Operating vehicles or machinery immediately following administration is inadvisable due to impaired coordination. Therefore, abstain from alcohol consumption while undergoing Tubitere 120mg Injection treatment to prevent harmful interactions.
The injectable medication Tubitere 120mg is frequently administered in the treatment of breast cancer, specific lung cancers, prostate cancer, stomach cancer, and cancers of the head and neck. Its mechanism of action involves inhibiting cellular growth and proliferation.
Tubitere 120mg Injection is administered intravenously by healthcare professionals in a clinical setting. This liquid medication is typically infused over a 60-minute period, with administrations scheduled at three-week intervals.
Regular blood work, including a complete blood count and liver function assessment, will be required before each Tubitere 120mg Injection administration. These tests monitor blood cell levels and liver health to ensure suitability for treatment. Low white blood cell counts can lead to fever or infections.
Alopecia is a frequently reported adverse reaction associated with Tubitere 120mg Injection. Hair regrowth typically occurs following discontinuation of Tubitere 120mg Injection. Nevertheless, irreversible hair loss can sometimes result. Seek medical advice if you experience hair loss concerns.
Administration of Tubitere 120mg Injection can lead to edema (swelling in the extremities) and serious allergic responses. Prophylactic corticosteroids (dexamethasone) are prescribed for three days, commencing one day before Tubitere 120mg Injection, to mitigate these risks. For patients with metastatic castration-resistant prostate cancer, dexamethasone is administered orally at twelve, three, and one hour prior to Tubitere 120mg Injection infusion.
The taxoid-class anticancer medication, Tubitere 120mg Injection, inhibits the proliferation and metastasis of cancerous cells.
Tubitere 120mg Injection
8,721
MRP 10,625
17% off